We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Innovations To Work With Debt Providers To Refinance Facility

Wed, 12th Jun 2019 18:16

(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the pair.

Shares in the company closed down 27% at 0.20 pence each.

In March, Amphion amended its loan facility it first agreed in 2014 but then amended last October. Then in April, the company pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt provider.

As part of the amendment in March, Amphion pledged 18.0 million shares in partner company Motif Bio PLC shares to act as security for the loan. The amendment in April saw the loan also be secured by the company's 18.4 million shares in Polarean.

As of Tuesday, the loan balance outstanding is about USD3.2 million, with 10.9 million Motif Bio shares held.

Shares in Motif Bio closed down 8.2% Wednesday at 3.49 pence.

"The board is working closely with the lender regarding potential resolution in connection with the collateral requirement and further announcements will be made as appropriate," the company said.

Amphion added: "The company remains highly cash constrained and continues to consider both its short term and medium term funding options and work with the company's note holders. The outstanding facility balance plus accrued interest are currently due for repayment on September 30."

Amphion retains its beneficial interest in all pledged shares, although it has transferred the legal title to the majority of these.

More News
14 Jun 2021 20:33

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

Read more
26 May 2021 21:28

IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million

IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million

Read more
26 May 2021 18:18

TRADING UPDATES: AVI Global sees strong results; Finsbury Food rebound

TRADING UPDATES: AVI Global sees strong results; Finsbury Food rebound

Read more
10 May 2021 15:52

IN BRIEF: Motif Bio 2020 loss narrows due to impairment in prior year

IN BRIEF: Motif Bio 2020 loss narrows due to impairment in prior year

Read more
29 Mar 2021 14:25

IN BRIEF: Motif Bio progresses reverse takeover, expects AIM return

IN BRIEF: Motif Bio progresses reverse takeover, expects AIM return

Read more
26 Feb 2021 20:20

LONDON TRADING UPDATES: Motif Bio Says Orange Avenue Buys Subsidiary

LONDON TRADING UPDATES: Motif Bio Says Orange Avenue Buys Subsidiary

Read more
27 Jan 2021 14:37

IN BRIEF: Motif Bio Making Progress On UK Drug Development Firm Buy

IN BRIEF: Motif Bio Making Progress On UK Drug Development Firm Buy

Read more
5 Jan 2021 15:04

IN BRIEF: Motif Bio Advancing Process To Complete Reverse Takeover

IN BRIEF: Motif Bio Advancing Process To Complete Reverse Takeover

Read more
12 Oct 2020 11:50

Cash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities

Cash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities

Read more
23 Sep 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Sep 2020 14:08

IN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes

IN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes

Read more
29 Jul 2020 15:39

IN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover

IN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover

Read more
29 Jul 2020 09:59

Motif Bio shares suspended from trading

(Sharecast News) - Pharmaceutical company Motif Bio saw its shares suspended from trading on Wednesday in order to satisfy AIM rules.

Read more
23 Jun 2020 08:48

CORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

CORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

Read more
22 Jun 2020 14:14

IN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

IN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.